首页> 美国卫生研究院文献>Molecules >Design of a Novel and Selective IRAK4 Inhibitor Using Topological Water Network Analysis and Molecular Modeling Approaches
【2h】

Design of a Novel and Selective IRAK4 Inhibitor Using Topological Water Network Analysis and Molecular Modeling Approaches

机译:基于拓扑水网络分析和分子建模方法的新型选择性IRAK4抑制剂的设计

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Protein kinases are deeply involved in immune-related diseases and various cancers. They are a potential target for structure-based drug discovery, since the general structure and characteristics of kinase domains are relatively well-known. However, the ATP binding sites in protein kinases, which serve as target sites, are highly conserved, and thus it is difficult to develop selective kinase inhibitors. To resolve this problem, we performed molecular dynamics simulations on 26 kinases in the aqueous solution, and analyzed topological water networks (TWNs) in their ATP binding sites. Repositioning of a known kinase inhibitor in the ATP binding sites of kinases that exhibited a TWN similar to interleukin-1 receptor-associated kinase 4 (IRAK4) allowed us to identify a hit molecule. Another hit molecule was obtained from a commercial chemical library using pharmacophore-based virtual screening and molecular docking approaches. Pharmacophoric features of the hit molecules were hybridized to design a novel compound that inhibited IRAK4 at low nanomolar levels in the in vitro assay.
机译:蛋白激酶与免疫相关疾病和各种癌症密切相关。它们是基于结构的药物发现的潜在靶标,因为激酶结构域的一般结构和特征是相对众所周知的。然而,作为目标位点的蛋白激酶中的ATP结合位点是高度保守的,因此难以开发选择性激酶抑制剂。为解决此问题,我们对水溶液中的26种激酶进行了分子动力学模拟,并分析了其ATP结合位点中的拓扑水网络(TWN)。在表现出与白介素1受体相关激酶4(IRAK4)类似的TWN的激酶的ATP结合位点中重新定位已知的激酶抑制剂,使我们能够鉴定出一个命中分子。使用基于药效团的虚拟筛选和分子对接方法,从商业化学库中获得了另一个命中分子。杂交命中分子的药理学特征,以设计出一种新型化合物,该化合物在体外测定中可在低纳摩尔水平上抑制IRAK4。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号